인적 번역의 예문에서 번역 방법 학습 시도.
전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
complement activation
complementactivering
마지막 업데이트: 2014-12-09
사용 빈도: 7
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
complement activation alternative pathway
complementactivering, via alternatieve route
마지막 업데이트: 2014-12-09
사용 빈도: 3
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
complement activation pathway, alternative
complementactivering, via alternatieve route
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
c76 complement activation alternative pathway
complementactivering, via alternatieve route
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
complement activation alternative pathway, nos
complementactivering, via alternatieve route
마지막 업데이트: 2014-12-09
사용 빈도: 2
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
complement activation alternative pathway, function
complementactivering, via alternatieve route
마지막 업데이트: 2014-12-09
사용 빈도: 2
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
the effects may result from complement activation.
de effecten kunnen het resultaat zijn van complementactivering.
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
mannan binding lectin pathway (complement activation)
mannose-bindend lectinecomplementroute
마지막 업데이트: 2014-12-09
사용 빈도: 2
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
mannan-binding lectin pathways (complement activation)
complementroute, mannosebindend lectine-
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
complement activations
complementactivatie
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
complement activation alternative pathway, function (observable entity)
complementactivering, via alternatieve route
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
14 attributed to the formation of igg antibodies and/ or complement activation.
de meeste van deze bijwerkingen kunnen worden toegeschreven aan de vorming van igg-antilichamen en/of complementactivering.
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
in ahus patients, uncontrolled terminal complement activation and the resulting complement- mediated thrombotic microangiopathy are blocked with soliris treatment.
bij ahus-patiënten worden door behandeling met soliris de activering van het terminale complement die niet onder controle is, en de daaruit voortvloeiende complement-gemedieerde trombotische microangiopathie, geblokkeerd.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
reduction in terminal complement activity was observed in all patients after commencement of soliris.
bij alle patiënten werd na aanvang van gebruik van soliris een vermindering van de activiteit van het terminale complement waargenomen.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
3 injection caused severe haemodynamic effects including death, probably as a result of complement activation.
er zijn geen klinische gegevens over het gebruik van visudyne bij patiënten onder anesthesie.
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
the majority of these reactions can be attributed to the formation of igg antibodies and/or complement activation.
de meeste van deze bijwerkingen kunnen worden toegeschreven aan de vorming van igg-antilichamen en/of complementactivering.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
all ahus patients treated with soliris when administered as recommended demonstrated rapid and sustained reduction in terminal complement activity.
alle ahus-patiënten die met soliris werden behandeld volgens de aanbevolen toediening, vertoonden een snelle en aanhoudende vermindering van de activiteit van het terminale complement.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
eculizumab preserves the early components of complement activation that are essential for opsonization of microorganisms and clearance of immune complexes.
eculizumab beschermt de vroege componenten van de complementactivering die essentieel zijn voor opsonisatie van micro-organismen en voor de klaring van immuuncomplexen.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
a reduction in terminal complement activity and an increase in platelet count relative to baseline were observed after commencement of soliris.
een vermindering van de activiteit van het terminale complement en een stijging van het aantal bloedplaatjes ten opzichte van de aanvangswaarden werden waargenomen na aanvang van gebruik van soliris.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
no clinically relevant complement activation was reported in clinical trials but anaphylactic reactions have been reported during post-marketing surveillance.
er werd geen klinisch relevante complementactivering gerapporteerd in de klinische onderzoeken, maar anafylactische reacties zijn gemeld gedurende postmarketing surveillance.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질: